{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-HCC", "anti-migration", "apoptosis", "sulfonate derivatives", "tetrandrine derivatives"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36704617", "DateRevised": {"Year": "2023", "Month": "02", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "01", "Day": "10"}], "Language": ["eng"], "ELocationID": ["1107824", "10.3389/fchem.2022.1107824"], "Journal": {"ISSN": "2296-2646", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in chemistry", "ISOAbbreviation": "Front Chem"}, "ArticleTitle": "A novel class of C14-sulfonate-tetrandrine derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.", "Pagination": {"StartPage": "1107824", "MedlinePgn": "1107824"}, "Abstract": {"AbstractText": ["Hepatocellular carcinoma (HCC), the most common malignancy of the liver, exhibits high recurrence and metastasis. Structural modifications of natural products are crucial resources of antitumor drugs. This study aimed to synthesize C-14 derivatives of tetrandrine and evaluate their effects on HCC. Forty C-14 sulfonate tetrandrine derivatives were synthesized and their <i>in vitro</i> antiproliferative was evaluated against four hepatoma (HepG-2, SMMC-7721, QGY-7701, and SK-Hep-1) cell lines. For all tested cells, most of the modified compounds were more active than the lead compound, tetrandrine. In particular, 14-O-(5-chlorothiophene-2-sulfonyl)-tetrandrine (<b>33</b>) exhibited the strongest antiproliferative effect, with half-maximal inhibitory concentration values of <b>1.65</b>, <b>2.89</b>, <b>1.77</b>, and <b>2.41</b>\u00a0\u03bcM for the four hepatoma cell lines, respectively. Moreover, <b>33</b> was found to induce apoptosis <i>via</i> a mitochondria-mediated intrinsic pathway <i>via</i> flow cytometry and western blotting analysis. In addition, colony formation, wound healing, and transwell assays demonstrated that <b>33</b> significantly inhibited HepG-2 and SMMC-7721 cell proliferation, migration, and invasion, indicating that it might potentially be a candidate for an anti-HCC therapy in the future."], "CopyrightInformation": "Copyright \u00a9 2023 Jiang, Xie, Zeng, Lan, Liu, Li, Ren, Chen and Pan."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medicine/State Key Laboratory of Functions and Applications of Medicinal Plants, Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Jiang", "ForeName": "Taibai", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, China."}], "LastName": "Xie", "ForeName": "Guangtong", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Department of Physiology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Zeng", "ForeName": "Zhirui", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China."}], "LastName": "Lan", "ForeName": "Junjie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medicine/State Key Laboratory of Functions and Applications of Medicinal Plants, Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Liu", "ForeName": "Hanfei", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medicine/State Key Laboratory of Functions and Applications of Medicinal Plants, Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Li", "ForeName": "Jinyu", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medicine/State Key Laboratory of Functions and Applications of Medicinal Plants, Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Ren", "ForeName": "Hai", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Department of Physiology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Precision Medicine Research Institute of Guizhou, Affiliated Hospital of Guizhou Medical University, Guiyang, China."}], "LastName": "Chen", "ForeName": "Tengxiang", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medicine/State Key Laboratory of Functions and Applications of Medicinal Plants, Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou University, Guiyang, China."}], "LastName": "Pan", "ForeName": "Weidong", "Initials": "W"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Chem", "NlmUniqueID": "101627988", "ISSNLinking": "2296-2646"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Anwanwan D., Singh S. K., Singh S., Saikam V., Singh R. (2020). Challenges in liver cancer and possible treatment approaches. Biochim. Biophys. Acta Rev. Cancer 1873, 188314. 10.1016/j.bbcan.2019.188314", "ArticleIdList": ["10.1016/j.bbcan.2019.188314", "PMC6981221", "31682895"]}, {"Citation": "Ashrafizadeh M., Najafi M., Makvandi P., Zarrabi A., Farkhondeh T., Samarghandian S. (2020). Versatile role of curcumin and its derivatives in lung cancer therapy. J. Cell. Physiol. 235, 9241\u20139268. 10.1002/jcp.29819", "ArticleIdList": ["10.1002/jcp.29819", "32519340"]}, {"Citation": "Bhagya N., Chandrashekar K. R. (2022). Autophagy and cancer: Can tetrandrine be a potent anticancer drug in the near future? Biomed. Pharmacother. 148, 112727. 10.1016/j.biopha.2022.112727", "ArticleIdList": ["10.1016/j.biopha.2022.112727", "35219119"]}, {"Citation": "Bhagya N., Chandrashekar K. R. (2016). Tetrandrine \u2013 a molecule of wide bioactivity. Phytochemistry 125, 5\u201313. 10.1016/j.phytochem.2016.02.005", "ArticleIdList": ["10.1016/j.phytochem.2016.02.005", "26899361"]}, {"Citation": "Chen S., Liu W., Wang K., Fan Y., Chen J., Ma J., et al. (2017). Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-\u03baB/MMP-9 signaling. PLOS One 12, e0173725. 10.1371/journal.pone.0173725", "ArticleIdList": ["10.1371/journal.pone.0173725", "PMC5348026", "28288190"]}, {"Citation": "Dimitroulis D., Damaskos C., Valsami S., Davakis S., Garmpis N., Spartalis E., et al. (2017). From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J. Gastroenterol. 23, 5282\u20135294. 10.3748/wjg.v23.i29.5282", "ArticleIdList": ["10.3748/wjg.v23.i29.5282", "PMC5550777", "28839428"]}, {"Citation": "Elmore S. (2007). Apoptosis: A review of programmed cell death. Toxicol. Pathol. 35, 495\u2013516. 10.1080/01926230701320337", "ArticleIdList": ["10.1080/01926230701320337", "PMC2117903", "17562483"]}, {"Citation": "Gao L. N., Feng Q. S., Zhang X. F., Wang Q. S., Cui Y. L. (2016). Tetrandrine suppresses articular inflammatory response by inhibiting pro-inflammatory factors via NF-\u03baB inactivation. J. Orthop. Res. 34, 1557\u20131568. 10.1002/jor.23155", "ArticleIdList": ["10.1002/jor.23155", "26748661"]}, {"Citation": "Gao X. Z., Lv X. T., Zhang R. R., Luo Y., Wang M. X., Chen J. S., et al. (2021). Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives. Bioorg. Chem. 109, 104694. 10.1016/j.bioorg.2021.104694", "ArticleIdList": ["10.1016/j.bioorg.2021.104694", "33601141"]}, {"Citation": "Heister P. M., Poston R. N. (2020). Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID\u201019. Pharmacol. Res. Perspect. 8, e00653. 10.1002/prp2.653", "ArticleIdList": ["10.1002/prp2.653", "PMC7503088", "32930523"]}, {"Citation": "Jamieson C., Moir E. M., Rankovic Z., Wishart G. (2006). Medicinal chemistry of hERG optimizations: Highlights and hang-ups. J. Med. Chem. 49, 5029\u20135046. 10.1021/jm060379l", "ArticleIdList": ["10.1021/jm060379l", "16913693"]}, {"Citation": "Kim D. W., Talati C., Kim R. (2017). Hepatocellular carcinoma (HCC): Beyond sorafenib\u2014chemotherapy. J. Gastrointest. Oncol. 8, 1968\u20131980. 10.21037/jgo.2016.09.07", "ArticleIdList": ["10.21037/jgo.2016.09.07", "PMC5401857", "28480065"]}, {"Citation": "Lan J., Huang L., Lou H., Chen C., Liu T., Hu S., et al. (2018). Design and synthesis of novel C14-urea-tetrandrine derivatives with potent anti-cancer activity. Eur. J. Med. Chem. 143, 1968\u20131980. 10.1016/j.ejmech.2017.11.007", "ArticleIdList": ["10.1016/j.ejmech.2017.11.007", "29133049"]}, {"Citation": "Lan J., Wang N., Huang L., Liu Y., Ma X., Lou H., et al. (2017). Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma. Eur. J. Med. Chem. 127, 554\u2013566. 10.1016/j.ejmech.2017.01.008", "ArticleIdList": ["10.1016/j.ejmech.2017.01.008", "28109948"]}, {"Citation": "Li D., Liu H., Liu Y., Zhang Q., Liu C., Zhao S., et al. (2017). Design, synthesis and biological activities of tetrandrine and fangchinoline derivatives as antitumer agents. Bioorg. Med. Chem. Lett. 27, 533\u2013536. 10.1016/j.bmcl.2016.12.029", "ArticleIdList": ["10.1016/j.bmcl.2016.12.029", "28057423"]}, {"Citation": "Lin Y. J., Peng S. F., Lin M. L., Kuo C. L., Lu K. W., Liao C. L., et al. (2016). Tetrandrine induces apoptosis of human nasopharyngeal carcinoma NPC-TW 076 cells through reactive oxygen species accompanied by an endoplasmic reticulum stress signaling pathway. Molecules 21, 1353. 10.3390/molecules21101353", "ArticleIdList": ["10.3390/molecules21101353", "PMC6273859", "27754332"]}, {"Citation": "Liu C., Chen K., Chen P. (2015a). Treatment of liver cancer. Cold Spring Harb. Perspect. Med. 5, a021535. 10.1101/cshperspect.a021535", "ArticleIdList": ["10.1101/cshperspect.a021535", "PMC4561392", "26187874"]}, {"Citation": "Liu W., Kou B., Ma Z. K., Tang X. S., Lv C., Ye M., et al. (2015b). Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells. Asian J. Androl. 17, 850\u2013853. 10.4103/1008-682X.142134", "ArticleIdList": ["10.4103/1008-682X.142134", "PMC4577603", "25677131"]}, {"Citation": "Ma J. W., Zhang Y., Li R., Ye J. C., Li H. Y., Zhang Y. K., et al. (2015). Tetrandrine suppresses human glioma growth by inhibiting cell survival, proliferation and tumour angiogenesis through attenuating STAT3 phosphorylation. Eur. J. Pharmacol. 764, 228\u2013239. 10.1016/j.ejphar.2015.06.017", "ArticleIdList": ["10.1016/j.ejphar.2015.06.017", "26086859"]}, {"Citation": "Newman D. J., Cragg G. M. (2020). Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 83, 770\u2013803. 10.1021/acs.jnatprod.9b01285", "ArticleIdList": ["10.1021/acs.jnatprod.9b01285", "32162523"]}, {"Citation": "Pistritto G., Trisciuoglio D., Ceci C., Garufi A., D\u2019Orazi G. (2016). Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies. Aging 8, 603\u2013619. 10.18632/aging.100934", "ArticleIdList": ["10.18632/aging.100934", "PMC4925817", "27019364"]}, {"Citation": "Rishton G. M. (2008). Natural products as a robust source of new drugs and drug leads: Past successes and present day issues. Am. J. Cardiol. 101, 43D\u201349D. 10.1016/j.amjcard.2008.02.007", "ArticleIdList": ["10.1016/j.amjcard.2008.02.007", "18474274"]}, {"Citation": "Sadeghi S., Davoodvandi A., Pourhanifeh M. H., Sharifi N., ArefNezhad R., Sahebnasagh R., et al. (2019). Anti-cancer effects of cinnamon: Insights into its apoptosis effects. Eur. J. Med. Chem. 178, 131\u2013140. 10.1016/j.ejmech.2019.05.067", "ArticleIdList": ["10.1016/j.ejmech.2019.05.067", "31195168"]}, {"Citation": "Shi X., Mao Y., Saffiotti U., Wang L., Rojanasakul Y., Leonard S. S., et al. (1995). Antioxidant activity of tetrandrine and its inhibition of quartz\u2010induced lipid peroxidation. J. Toxicol. Environ. Health 46, 233\u2013248. 10.1080/15287399509532031", "ArticleIdList": ["10.1080/15287399509532031", "7563220"]}, {"Citation": "Siegel R. L., Miller K. D., Fuchs H. E., Jemal A. (2022). Cancer statistics, 2022. CA Cancer J. Clin. 72, 7\u201333. 10.3322/caac.21708", "ArticleIdList": ["10.3322/caac.21708", "35020204"]}, {"Citation": "Song J. R., Lan J. J., Chen C., Hu S. C., Song J. R., Liu W., et al. (2018). Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents. Medchemcomm 9, 1131\u20131141. 10.1039/C8MD00125A", "ArticleIdList": ["10.1039/C8MD00125A", "PMC6072089", "30109000"]}, {"Citation": "Sung H., Ferlay J., Siegel R. L., Laversanne M., Soerjomataram I., Jemal A., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. 10.3322/caac.21660", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Wei X., Qu T. L., Yang Y. F., Xu J. F., Li X. W., Zhao Z. B., et al. (2016). Design and synthesis of new tetrandrine derivatives and their antitumor activities. J. Asian Nat. Prod. Res. 18, 966\u2013975. 10.1080/10286020.2016.1188085", "ArticleIdList": ["10.1080/10286020.2016.1188085", "27244089"]}, {"Citation": "Wu C. Z., Lai L., Hu X., Lei R. R., Yang Y. F. (2013). Synthesis and antitumor activity of tetrandrine derivatives. J. Asian Nat. Prod. Res. 15, 993\u20131002. 10.1080/10286020.2013.823950", "ArticleIdList": ["10.1080/10286020.2013.823950", "23944846"]}, {"Citation": "Yi K., Liu S., Liu P., Luo X., Zhao J., Yan F., et al. (2022). Synergistic antibacterial activity of tetrandrine combined with colistin against MCR-mediated colistin-resistant Salmonella. Biomed. Pharmacother. 149, 112873. 10.1016/j.biopha.2022.112873", "ArticleIdList": ["10.1016/j.biopha.2022.112873", "35349932"]}, {"Citation": "Zeeshan R., Mutahir Z. (2017). Cancer metastasis - tricks of the trade. Bosn. J. Basic Med. Sci. 17, 172\u2013182. 10.17305/bjbms.2017.1908", "ArticleIdList": ["10.17305/bjbms.2017.1908", "PMC5581965", "28278128"]}, {"Citation": "Zhang Y. X., Liu X. M., Wang J., Li J., Liu Y., Zhang H., et al. (2015). Inhibition of AKT/FoxO3a signaling induced puma expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine. Cancer Biol. Ther. 16, 965\u2013975. 10.1080/15384047.2015.1040950", "ArticleIdList": ["10.1080/15384047.2015.1040950", "PMC4622009", "25893985"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "25"}, {"Year": "2022", "Month": "12", "Day": "8"}, {"Year": "2023", "Month": "1", "Day": "27", "Hour": "2", "Minute": "29"}, {"Year": "2023", "Month": "1", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["36704617", "PMC9871304", "10.3389/fchem.2022.1107824", "1107824"]}}], "PubmedBookArticle": []}